Cargando…
Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis
Resveratrol, a trans-stilbene polyphenolic compound and its synthetic analogs are widely used bioactive molecules due to their remarkable chemo-preventive potential. Here, we have identified a novel synthetic trans-stilbene compound, Z-DAN-11 ((Z)-3-(3, 4-dimethoxyphenyl)-2-(3, 4, 5-trimethoxyphenyl...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906627/ https://www.ncbi.nlm.nih.gov/pubmed/29670107 http://dx.doi.org/10.1038/s41419-018-0476-2 |
_version_ | 1783315411937263616 |
---|---|
author | Parida, Pravat Kumar Mahata, Barun Santra, Abhisek Chakraborty, Sohini Ghosh, Zhumur Raha, Sanghamitra Misra, Anup Kumar Biswas, Kaushik Jana, Kuladip |
author_facet | Parida, Pravat Kumar Mahata, Barun Santra, Abhisek Chakraborty, Sohini Ghosh, Zhumur Raha, Sanghamitra Misra, Anup Kumar Biswas, Kaushik Jana, Kuladip |
author_sort | Parida, Pravat Kumar |
collection | PubMed |
description | Resveratrol, a trans-stilbene polyphenolic compound and its synthetic analogs are widely used bioactive molecules due to their remarkable chemo-preventive potential. Here, we have identified a novel synthetic trans-stilbene compound, Z-DAN-11 ((Z)-3-(3, 4-dimethoxyphenyl)-2-(3, 4, 5-trimethoxyphenyl) acrylonitrile) which shows remarkable efficacy in blocking tumor growth and progression both in vitro and in vivo. Z-DAN-11 inhibits proliferation of cancer cells in vitro through microtubule depolymerization that induced G2/M arrest and consequently leads to apoptotic cell death. More importantly, Z-DAN-11 shows limited cytotoxicity to normal cells as compared to cancer cells. Quite interestingly, we have found that Z-DAN-11-mediated ROS production helps in dramatic alteration in the mitochondrial redox status which critically contributes to the apoptosis. Mechanistic studies reveal that Z-DAN-11 induces the expression of pro-apoptotic proteins and decreases anti-apoptotic protein expression that decisively helps in the activation of caspase 8, caspase 9, and caspase 3, leading to cleavage of PARP1 and cell death via intrinsic and extrinsic pathways of apoptosis. Moreover, Z-DAN-11-mediated apoptosis of cancer cells is through a partial p53-dependent pathway, since both HCT116 p53(−/−) cells as well as p53-silenced cells (siRNA) were able to block apoptosis partially but significantly. Importantly, Z-DAN-11 also imparts its anti-tumorigenic effect by inhibiting clonogenic property and anchorage-independent growth potential of cancer cells at concentrations at least 10 times lower than that required for inducing apoptosis. Finally, in vivo study with immuno-competent syngeneic mice shows Z-DAN-11 to be able to impede tumor progression without any adverse side-effects. Hence, we identified a novel, synthetic trans-stilbene derivative with anti-tumorigenic potential which might tremendously help in devising potential therapeutic strategy against cancer. |
format | Online Article Text |
id | pubmed-5906627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-59066272018-06-05 Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis Parida, Pravat Kumar Mahata, Barun Santra, Abhisek Chakraborty, Sohini Ghosh, Zhumur Raha, Sanghamitra Misra, Anup Kumar Biswas, Kaushik Jana, Kuladip Cell Death Dis Article Resveratrol, a trans-stilbene polyphenolic compound and its synthetic analogs are widely used bioactive molecules due to their remarkable chemo-preventive potential. Here, we have identified a novel synthetic trans-stilbene compound, Z-DAN-11 ((Z)-3-(3, 4-dimethoxyphenyl)-2-(3, 4, 5-trimethoxyphenyl) acrylonitrile) which shows remarkable efficacy in blocking tumor growth and progression both in vitro and in vivo. Z-DAN-11 inhibits proliferation of cancer cells in vitro through microtubule depolymerization that induced G2/M arrest and consequently leads to apoptotic cell death. More importantly, Z-DAN-11 shows limited cytotoxicity to normal cells as compared to cancer cells. Quite interestingly, we have found that Z-DAN-11-mediated ROS production helps in dramatic alteration in the mitochondrial redox status which critically contributes to the apoptosis. Mechanistic studies reveal that Z-DAN-11 induces the expression of pro-apoptotic proteins and decreases anti-apoptotic protein expression that decisively helps in the activation of caspase 8, caspase 9, and caspase 3, leading to cleavage of PARP1 and cell death via intrinsic and extrinsic pathways of apoptosis. Moreover, Z-DAN-11-mediated apoptosis of cancer cells is through a partial p53-dependent pathway, since both HCT116 p53(−/−) cells as well as p53-silenced cells (siRNA) were able to block apoptosis partially but significantly. Importantly, Z-DAN-11 also imparts its anti-tumorigenic effect by inhibiting clonogenic property and anchorage-independent growth potential of cancer cells at concentrations at least 10 times lower than that required for inducing apoptosis. Finally, in vivo study with immuno-competent syngeneic mice shows Z-DAN-11 to be able to impede tumor progression without any adverse side-effects. Hence, we identified a novel, synthetic trans-stilbene derivative with anti-tumorigenic potential which might tremendously help in devising potential therapeutic strategy against cancer. Nature Publishing Group UK 2018-04-18 /pmc/articles/PMC5906627/ /pubmed/29670107 http://dx.doi.org/10.1038/s41419-018-0476-2 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Parida, Pravat Kumar Mahata, Barun Santra, Abhisek Chakraborty, Sohini Ghosh, Zhumur Raha, Sanghamitra Misra, Anup Kumar Biswas, Kaushik Jana, Kuladip Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis |
title | Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis |
title_full | Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis |
title_fullStr | Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis |
title_full_unstemmed | Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis |
title_short | Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis |
title_sort | inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving g2/m arrest, and p53-dependent apoptosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906627/ https://www.ncbi.nlm.nih.gov/pubmed/29670107 http://dx.doi.org/10.1038/s41419-018-0476-2 |
work_keys_str_mv | AT paridapravatkumar inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis AT mahatabarun inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis AT santraabhisek inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis AT chakrabortysohini inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis AT ghoshzhumur inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis AT rahasanghamitra inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis AT misraanupkumar inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis AT biswaskaushik inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis AT janakuladip inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis |